CUAMC
KRRO icon

China Universal Asset Management Company’s Korro Bio KRRO Stock Holding History

China Universal Asset Management Company’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$1K – 427
2022
Q3 		$1K Buy
+7
New +$711 ﹤0.01% 398

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

China Universal Asset Management Company's KRRO Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Korro Bio (KRRO) in Q4 2022, closing a stake of 7 shares — an estimated $1K sold.

China Universal Asset Management Company first reported a position in KRRO in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 49 funds tracked by Wall St. Rank hold KRRO as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Korro Bio position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 7 Korro Bio shares in Q4 2022, an estimated $1K.
  • China Universal Asset Management Company first reported a position in Korro Bio in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Korro Bio position peaked at $1K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Korro Bio as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.